Cover |
Mar. 11, 2026 |
|---|---|
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | This Current Report on Form 8-K/A (this “Amendment”) amends and restates in its entirety the Current Report on Form 8-K filed by Tenon Medical, Inc. (the “Company”) with the U.S. Securities and Exchange Commission (the “SEC”) on March 17, 2026 (the “Original Report”). This Amendment amends the Original Report solely to: (i) correct the aggregate principal amount of the Notes from $4.3 million to $5.16 million, (ii) replace Exhibit 4.1 with a form of the Note that has correct floor price of $0.1567. Other than such changes to the Original Report described above, there are no other changes to the Original Report. |
| Document Period End Date | Mar. 11, 2026 |
| Entity File Number | 001-41364 |
| Entity Registrant Name | TENON MEDICAL, INC. |
| Entity Central Index Key | 0001560293 |
| Entity Tax Identification Number | 45-5574718 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 104 Cooper Court |
| Entity Address, City or Town | Los Gatos |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 95032 |
| City Area Code | 408 |
| Local Phone Number | 649-5760 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
| Common Stock, par value $0.001 per share | |
| Title of 12(b) Security | Common Stock, par value $0.001 per share |
| Trading Symbol | TNON |
| Security Exchange Name | NASDAQ |
| Warrants | |
| Title of 12(b) Security | Warrants |
| Trading Symbol | TNONW |
| Security Exchange Name | NASDAQ |